David Smith V. - 01 Mar 2022 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role
Director
Signature
/s/ Brian Burkavage, Attorney-in-Fact for David V. Smith
Issuer symbol
IOBT
Transactions as of
01 Mar 2022
Net transactions value
$0
Form type
4
Filing time
03 Mar 2022, 15:30:24 UTC
Previous filing
14 Jan 2022
Next filing
31 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOBT Stock Option (Right to Buy) Award $0 +28,019 $0.000000 28,019 01 Mar 2022 Common Stock 28,019 $6.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest monthly over three years from the vesting commencement date of March 1, 2022, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control.